NFRA issues detailed rules for non-motor insurance reform; loading rate capped at 30% for major insurers

Reinsurance Group of America, Incorporated, a provider of life and health reinsurance solutions, has released new research that evaluates the potential effects of incretin-based therapies, including GLP-1 medications, on mortality and morbidity.These drugs, used for both weight management and diabetes treatment, were assessed across four regions: the United States, United Kingdom, Canada, and Hong